We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+6.72%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$616B
AUM Growth
+$31B
Cap. Flow
-$1.19B
Cap. Flow %
-0.19%
Top 10 Hldgs %
18.88%
Holding
2,692
New
121
Increased
947
Reduced
1,282
Closed
130

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$1.86B
2
VMW
VMware, Inc
VMW
+$1.49B
3
AVGO icon
Broadcom
AVGO
+$1.29B
4
SRE icon
Sempra
SRE
+$1.26B
5
BKNG icon
Booking.com
BKNG
+$1.12B

Top Sells

Rank Stock Value
1
PYPL icon
PayPal
PYPL
+$1.66B
2
HCA icon
HCA Healthcare
HCA
+$1.02B
3
BNY
Bank of New York Mellon
BNY
+$949M
4
AMT icon
American Tower
AMT
+$931M
5
FRC
First Republic Bank
FRC
+$890M

Sector Composition

Rank Sector Weight
1 Healthcare 17.07%
2 Financials 16.19%
3 Technology 16.15%
4 Consumer Discretionary 13.93%
5 Industrials 9.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ONDK
2626
DELISTED
On Deck Capital, Inc.
ONDK
– –
-18,433
Closed -$86K
AKCA
2627
DELISTED
Akcea Therapeutics Inc
AKCA
– –
-955,568
Closed -$26.4M
ENT
2628
DELISTED
Global Eagle Entertainment Inc.
ENT
– –
-489
Closed -$42K
ACHN
2629
DELISTED
Achillion Pharmaceuticals
ACHN
– –
-25,228
Closed -$113K
GHDX
2630
DELISTED
Genomic Health, Inc.
GHDX
– –
-9,178
Closed -$295K
IPOA.U
2631
DELISTED
Social Capital Hedosophia Holdings Corp.
IPOA.U
– –
-1,000,000
Closed -$10.6M
CHSP
2632
DELISTED
Chesapeake Lodging Trust
CHSP
– –
-1,309,218
Closed -$35.3M
CIC.U
2633
DELISTED
Capitol Investment Corp. IV
CIC.U
– –
-954,700
Closed -$9.66M
PETX
2634
DELISTED
Aratana Therapeutics, Inc.
PETX
– –
-26,200
Closed -$161K
INSY
2635
DELISTED
Insys Therapeutics, Inc.
INSY
– –
-129,483
Closed -$1.15M
FTD
2636
DELISTED
FTD Companies, Inc. Common Stock
FTD
– –
-13,575
Closed -$177K
NAVB
2637
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
– –
-3,500
Closed -$29K
SGYP
2638
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
– –
-50,707
Closed -$147K
SN
2639
DELISTED
Sanchez Energy Corporation
SN
– –
-31,987
Closed -$154K
ESND
2640
DELISTED
Essendant Inc.
ESND
– –
-39,074
Closed -$515K
KND
2641
DELISTED
Kindred Healthcare
KND
– –
-29,023
Closed -$197K
OAKS
2642
DELISTED
Five Oaks Investment Corp.
OAKS
– –
-30,565
Closed -$136K
RSO
2643
DELISTED
Resource Capital Corp.
RSO
– –
-20,250
Closed -$218K
SCMP
2644
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
– –
-17,373
Closed -$205K
WAC
2645
DELISTED
Walter Investment Mgt Corp
WAC
– –
-16,168
Closed -$10K
RXDX
2646
DELISTED
Ignyta, Inc.
RXDX
– –
-359,359
Closed -$4.44M
ENZY
2647
DELISTED
Enzymotec Ltd
ENZY
– –
-166,445
Closed -$458K
RT
2648
DELISTED
Ruby Tuesday Georgia
RT
– –
-28,400
Closed -$61K
OME
2649
DELISTED
Omega Protein
OME
– –
-16,280
Closed -$271K
TMUSP
2650
DELISTED
T-Mobile US, Inc.5.50% Mandatory Convertible Preferred Stock, Series A
TMUSP
– –
-132,022
Closed -$13.2M
104 105
106
107 108

Similar funds

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

T. Rowe Price Associates's Q4 2017 Portfolio in Review

As of Q4 2017, T. Rowe Price Associates held 2,692 positions worth $616B, up 5.3% from $585B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

T. Rowe Price Associates's Q4 2017 filing shows 121 new, 947 increased, 1,282 reduced and 130 closed positions. Its largest new stake was CarGurus: 13,060,603 shares worth $374M. The largest sale was PayPal, an estimated $1.66B.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 18% a quarter earlier, followed by Financials and Technology.

  • T. Rowe Price Associates's largest Q4 2017 buy was CarGurus: 13,060,603 shares worth $374M.
  • T. Rowe Price Associates added most to Tesla in Q4 2017, an estimated $1.86B increase.
  • T. Rowe Price Associates's biggest Q4 2017 reduction was PayPal, cutting an estimated $1.66B.
  • T. Rowe Price Associates fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $483M.
  • T. Rowe Price Associates's ten largest holdings make up 19% of its $616B portfolio in Q4 2017.
  • T. Rowe Price Associates opened 121 new positions and closed 130 in Q4 2017.
  • T. Rowe Price Associates's portfolio value rose 5.3% quarter-over-quarter to $616B.

Based on T. Rowe Price Associates's 13F filing for Q4 2017, filed 14 Feb 2018.